Sight Sciences CTO sells shares for RSU taxes

Sight Sciences, Inc. Chief Technology Officer David Badawi reported an open-market sale of 7,418 shares of common stock at a weighted average price of $5.508 per share.

Rhea-AI Filing Summary

Sight Sciences, Inc. Chief Technology Officer David Badawi reported an open-market sale of 7,418 shares of common stock at a weighted average price of $5.508 per share. According to the footnotes, the sale was made to cover his tax liability arising from the vesting of restricted stock units.

After this transaction, Badawi directly held 1,982,872 shares of common stock and related equity, including 1,813,950 shares of common stock and 168,922 shares that will be acquired upon future vesting and settlement of unvested RSUs. The transaction represents a small portion of his overall equity position.

Insider Trade Summary 10b5-1

Net Seller: 7,418 shares

Net Sell 1 txn

Insider Badawi David

Role Chief Technology Officer

Sold 7,418 shs ($41K)

Type	Security	Shares	Price	Value
Sale	Common Stock	7,418	$5.508	$41K

Holdings After Transaction: Common Stock — 1,982,872 shares (Direct)

Footnotes (3)

1. F1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
2. F2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.37 to $5.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Includes (i) 1,813,950 shares of Common Stock, and (ii) 168,922 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

Key Figures

Shares sold: 7,418 shares Weighted average sale price: $5.508 per share Sale price range: $5.37–$5.62 per share +3 more

6 metrics

Shares sold 7,418 shares Open-market sale on 2026-07-06 to cover tax liability

Weighted average sale price $5.508 per share Common stock sale across multiple trades

Sale price range $5.37–$5.62 per share Multiple transactions within this range

Total holdings after transaction 1,982,872 shares Shares and RSU-related interests following sale

Common stock held 1,813,950 shares Portion of post-transaction holdings in common stock

Unvested RSU-related shares 168,922 shares To be acquired upon future RSU vesting and settlement

Key Terms

restricted stock units ("RSUs"), weighted average price, vesting, settlement, +1 more

5 terms

restricted stock units ("RSUs") financial

"in connection with the vesting of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"Reflects the weighted average price at which the shares of Common Stock were sold."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vesting financial

"in connection with the vesting of restricted stock units ("RSUs")."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

settlement financial

"shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs"

Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sight Sciences (SGHT) CTO David Badawi report in this Form 4?

David Badawi reported selling 7,418 shares of Sight Sciences common stock. The sale was an open-market transaction with a weighted average price of $5.508 per share, primarily to cover tax liabilities from recently vested restricted stock units.

How many Sight Sciences (SGHT) shares did the CTO sell and at what price?

He sold 7,418 shares of common stock at a weighted average price of $5.508 per share. Footnotes state the individual trades occurred between $5.37 and $5.62 per share across multiple transactions within that price range.

Why did the Sight Sciences (SGHT) CTO sell shares in this transaction?

The filing states the shares were sold to cover David Badawi’s tax liability related to the vesting of restricted stock units. Such tax-driven sales are typically linked to compensation events rather than discretionary portfolio changes.

What are David Badawi’s holdings in Sight Sciences (SGHT) after the sale?

Following the transaction, he held 1,982,872 shares in total. This includes 1,813,950 shares of common stock and 168,922 additional shares that will be acquired when currently unvested restricted stock units vest and settle in the future.

How significant is this Sight Sciences (SGHT) insider sale relative to the CTO’s position?

The 7,418 shares sold are small compared with David Badawi’s 1,982,872 total shares and RSU-based interests after the transaction. The filing frames the sale as tax-related rather than a large reduction in his overall ownership stake.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 07:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Badawi David

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/06/2026		S		7,418(1)	D	$5.508(2)	1,982,872(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.37 to $5.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes (i) 1,813,950 shares of Common Stock, and (ii) 168,922 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden, Attorney-in-Fact for David Badawi	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)